Ihle; Nathan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ihle; Nathan.The latest application filed is for "weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates".
- Ihle; Nathan - Bothell WA
- Ihle; Nathan - Perkasie PA
| Patent | Date |
|---|---|
| Weekly Dosing Regimens For Anti-cd30 Vc-pab-mmae Antibody Drug-conjugates App 20170281794 - Sievers; Eric ; et al. | 2017-10-05 |
| Weekly Dosing Regimens For Anti-cd30 Vc-pab-mmae Antibody Drug-conjugates App 20160129130 - Sievers; Eric ; et al. | 2016-05-12 |
| Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates Grant 9,211,319 - Sievers , et al. December 15, 2 | 2015-12-15 |
| Weekly Dosing Regimens for Anti-CD30 VC-PAB-MMAE Antibody Drug-Conjugates App 20110268751 - Sievers; Eric ; et al. | 2011-11-03 |
| Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets Grant 5,455,243 - Duggan , et al. October 3, 1 | 1995-10-03 |
| Fibrinogen receptor antagonists Grant 5,397,791 - Hartman , et al. March 14, 1 | 1995-03-14 |
| Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets Grant 5,281,585 - Duggan , et al. January 25, 1 | 1994-01-25 |
| Fibrinogen receptor antagonists Grant 5,264,420 - Duggan , et al. November 23, 1 | 1993-11-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 